Ontology highlight
ABSTRACT: Background
There is currently no treatment known to alter the course of coronavirus disease 2019 (COVID-19). Convalescent plasma has been used to treat a number of infections during pandemics, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle Eastern respiratory syndrome coronavirus (MERS-CoV) and now severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).Objectives
To summarize the existing literature and registered clinical trials on the efficacy and safety of convalescent plasma for treating coronaviruses, and discuss issues of feasibility, and donor and patient selection.Sources
A review of articles published in PubMed was performed on 13 July 2020 to summarize the currently available evidence in human studies for convalescent plas
SUBMITTER: Wooding DJ
PROVIDER: S-EPMC7417293 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature